View Item 

Show simple item record

The Role of Arachidonic Acid Metabolites in Mononuclear Phagocytic Cell Interactions
dc.contributor.authorKunkel, Steven L.en_US
dc.contributor.authorChensue, Stephen W.en_US
dc.date.accessioned2010-04-01T14:43:04Z
dc.date.available2010-04-01T14:43:04Z
dc.date.issued1986-03en_US
dc.identifier.citationKunkel, Steven L.; Chensue, Stephen W. (1986). "The Role of Arachidonic Acid Metabolites in Mononuclear Phagocytic Cell Interactions." International Journal of Dermatology 25(2): 83-89. <http://hdl.handle.net/2027.42/65162>en_US
dc.identifier.issn0011-9059en_US
dc.identifier.issn1365-4632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65162
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3516896&dopt=citationen_US
dc.format.extent3043259 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1986 Blackwell Science Ltden_US
dc.titleThe Role of Arachidonic Acid Metabolites in Mononuclear Phagocytic Cell Interactionsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology. University of Michigan Medical School, Ann Arbor, Michiganen_US
dc.identifier.pmid3516896en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65162/1/j.1365-4362.1986.tb04543.x.pdf
dc.identifier.doi10.1111/j.1365-4362.1986.tb04543.xen_US
dc.identifier.sourceInternational Journal of Dermatologyen_US
dc.identifier.citedreferenceKurzock R, Lieb CC Biochemical studies of human semen: II. The action of semen on the human uterus. Proc Soc Exp Biol Med. 1930 ; 28 : 268 – 271.en_US
dc.identifier.citedreferenceGoldblalt MW. A depressor substance in seminal fluid. J Soc Chem Ind. 1933 ; 52 : 1056 – 1059.en_US
dc.identifier.citedreferencevon Euler US On the specific vasodilitating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol (London). 1936 ; 88 : 213 – 219.en_US
dc.identifier.citedreferenceBergstrom S, Sjovall J. Studies on prostaglandins: occurrence, formation, and biological actions. Acta. Physiol Scand. 1959 ; 158 : 1 – 52.en_US
dc.identifier.citedreferenceBergstrom S, Ryhage R, Samuelsson B. The structure of prostaglandins E 1, F 1 and F 2. Acta Chem Scand [B]. 1962 ; 16 : 501 – 511.en_US
dc.identifier.citedreferenceVane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971 ; 231 : 232 – 235.en_US
dc.identifier.citedreferenceFeldberg W, Kellaway CN. Liberation of hislamine and formation of lysolecithin-like substances by cobra venom. J Physiol. 1938 ; 94 : 187 – 192.en_US
dc.identifier.citedreferenceOrange RR, Austin KF. Slow-reacting substances of anaphylaxis. Adv Immunol. 1969 ; 10 : 105 – 111.en_US
dc.identifier.citedreferenceMurphy RC, Hammarstrom S, Samuelsson B. Leukotriene C a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA. 1979 ; 79 : 4275 – 4281.en_US
dc.identifier.citedreferenceBorgeat P, Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. J Biol Chem 1979 ; 254 : 2643 – 2646.en_US
dc.identifier.citedreferenceGoetzl EJ, Pickett WC. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs ) J Immunol. 1980 ; 125 : 1789 – 1791.en_US
dc.identifier.citedreferenceFord-Hutchinson AW, Bray, MA. Doig, MU, et al. Leukotriene B 4 :a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 ; 286 : 264 – 265.en_US
dc.identifier.citedreferenceShowell HJ, Naccache PH, Borgeat P, et al. Characterization of the secretory activity of leukotriene B 4 for rabbit neutrophils. J Immunol. 1982 ; 128 : 811 – 816.en_US
dc.identifier.citedreferenceSherhan, CN, Radin, A, Smolen JE, et al. Leukotriene B 4 is a complete secretogogue for human neutrophils: a kinetic analysis. Biochem Biophys Res Commun. 1982 ; 107 : 1006 – 1012.en_US
dc.identifier.citedreferenceO'Flaherty JT. Kreutzer DL, Ward PA. Effects of PGE 1, PGE 2, and PCF 2Α on neutrophil activation. Prostaglandins. 1979 ; 17 : 201 – 208.en_US
dc.identifier.citedreferenceRivkin I, Rosenblatt J, Becker EL. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. J Immunol. 1975 ; 115 : 1126 – 1134.en_US
dc.identifier.citedreferenceFantone JC, Kinnes DA. Proslaglandin E, and prostaglandin I 2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun. 1983 ; 113 : 506 – 512.en_US
dc.identifier.citedreferenceScott WA, Zrike JM, Hamill AL, et al. Regulation of ararhidonic acid metabolites in macrophages. J Exp Med. 1980 ; 152 : 324 – 335.en_US
dc.identifier.citedreferenceStossel TP. Mason RJ, Smith AL. Lipid peroxidation by human blood phagocytes. J Clin Invest. 1974 ; 54 : 638 – 645.en_US
dc.identifier.citedreferenceMason RJ, Stossel TP, Vaughn M. Lipds of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest. 1972 ; 51 : 2399 – 2407.en_US
dc.identifier.citedreferenceSahn S, Lin WS. Lipid composition of human alveolar macrophages. Inflammation. 1977 ; 2 : 83 – 96.en_US
dc.identifier.citedreferenceBonney RJ, Wightman PD, Davies P. Selective inhibitors of lecithin biosynthesis in mouse peritoneal macrophdges. Biochem Pharmacol. 1979 ; 28 : 2471 – 2478.en_US
dc.identifier.citedreferenceRouzer CA, Scott WA, Kempe J, et al. Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Natl Acad Sci USA. 1980 ; 77 : 4279 – 4282.en_US
dc.identifier.citedreferenceHsueh W, Desai U, Gonzaley-Crussi J. Two phospholipase pools for prostaglandin synthesis in macrophages. Nature 1981 ; 290 : 710 – 713.en_US
dc.identifier.citedreferenceHumes JL, Sadowski S, Galavage M. Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J Biol Chem. 1982 ; 257 : 1591 – 1594.en_US
dc.identifier.citedreferenceKunkel SL, Chensue SW, Spengler M, et al. Effects of arachidonic acid metabolites and their metabolic inhibitors of interleukin-1 production. In : Kluger MJ, Oppenheim JJ, Powanda MC, eds. The physiologic, metabolic, and immunologic actions of interleukin-1. New York : Alan R Liss, 1985 : 297 – 307.en_US
dc.identifier.citedreferenceKurland JI Bockman R Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages J Exp Med. 1978 ; 147 : 952 – 957.en_US
dc.identifier.citedreferenceBoch MK, Brashler JR, Hammerstrom S. Identification of leukotriene C-1 as a major component of slow-reacting substance from rat mononuclear cells. J Immunol. 1980 ; 125 : 115 – 117.en_US
dc.identifier.citedreferenceRoubin R, Benveniste J. Release of leukotriene C (LTC) and D (LTD) from inflammatory macrophages during phagocytosis of zymosan and bacteria. Agents Actions. 1981 ; 11 : 578 – 579.en_US
dc.identifier.citedreferenceKunkel SL, Chensue SW, Mouton C, et al. Role of lipoxygenase products in murine pulmonary granuloma formation. J Clin Invest. 1984 ; 74 : 514 – 524.en_US
dc.identifier.citedreferenceScott WA, Pawlowski NA, Andreach M, et al. Resting macrophages produce distinct metabolites, from exogenous arachidonic acid. J Exp Med. 1982 ; 155 : 535 – 547.en_US
dc.identifier.citedreferenceScott WA, Pawlowski NA, Murray HW, et al. Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med. 1982 ; 155 : 1148 – 1160.en_US
dc.identifier.citedreferenceHsueh W, Kuhn C, Needleman P. Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J. 1979 ; 184 : 345 – 354.en_US
dc.identifier.citedreferenceKunkel SL, Chensue SW. Prostaglandins and the regulation of immune responses. Adv Inflam Res. 1984 ; 7 : 93 – 109.en_US
dc.identifier.citedreferenceWilliams TJ, Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 ; 246 : 215 – 217.en_US
dc.identifier.citedreferenceKurland JI, Kincade PW, Moore MAS. Regulation of B cell clonal proliferation by stimulatory and inhibitory macrophage-derived factors. J Exp Med. 1977 ; 146 : 1420 – 1435.en_US
dc.identifier.citedreferenceStobo JD, Kennedy MS, Goldyne MC. Prostaglandin E modulation of the mitogenic response of human T cells. J Clin Invest. 1979 ; 64 : 1188 – 1195.en_US
dc.identifier.citedreferenceKorn HS, Anderson SJ, Fischer DG. Regulation of human natural killing: I. The role of monocytes, interferon, and prostaglandins. J Immunol. 1981 ; 127 : 2007 – 2013.en_US
dc.identifier.citedreferenceHenney CS, Bourne HR, Lichtenstein LM. The role of cyclic AMP in the specific cytolytic activity of lymphocytes. J Immunol. 1971 ; 108 : 1526 – 1534.en_US
dc.identifier.citedreferenceGordon D, Bray MA, Morley J. Control of lymphokine secretion by prostaglandins. Nature. 1976 ; 262 : 401 – 402.en_US
dc.identifier.citedreferenceBray MA, Gordon D, Morley J. Prostaglandins as regulators in cellular immunity. Prostaglandin Med. 1978 ; 1 : 183 – 190.en_US
dc.identifier.citedreferenceBaker PE, Fahey JV, Munck A. Prostaglandin inhibition of T cell proliferation is mediated at two levels. Cell Immunol. 1981 ; 61 : 52 – 60.en_US
dc.identifier.citedreferenceRappaport RS, Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med. 1982 ; 155 : 943 – 948.en_US
dc.identifier.citedreferenceFulton AM, Levy JG. The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells. Cell Immunol. 1980 ; 52 : 29 – 37.en_US
dc.identifier.citedreferenceGoodwin JS, Webb DR. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 ; 15 : 106 – 113.en_US
dc.identifier.citedreferenceSmith RL, Weidemann MJ. Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages. Biochem Biophys Res Commun. 1980 ; 97 : 973 – 980.en_US
dc.identifier.citedreferenceSnider ME, Fertel RN, Zwilling BS. Prostaglandin regulation of macrophage function: effect of endogenous and exogenous prostaglandins. Cell Immunol. 1982 ; 74 : 234 – 242.en_US
dc.identifier.citedreferencePelus LM, Broxmeyer HE, Kurland JL. Regulation of macrophage and granulocyte proliferation. J Exp Med. 1979 ; 150 : 277 – 292.en_US
dc.identifier.citedreferenceSnyder DS, Beller DI, Unanue ER. Prostaglandin modulate macrophage la expression. Nature. 1982 ; 299 : 163 – 165.en_US
dc.identifier.citedreferenceKunkel SL, Chensue SW, Plewa MC, et al. Macrophage function in the Schistosoma mansoni egg-induced pulmonary granuloma: role of arachidonic acid metabolites in macrophage la antigen expression. Am J Pathol. 1984 ; 114 : 240 – 249.en_US
dc.identifier.citedreferenceZurier RB, Quagliata F. Effects of prostaglandin E 1 on adjuvant arthritis. Nature. 1971 ; 234 : 304 – 305.en_US
dc.identifier.citedreferenceChensue SW, Kunkel SL, Ward PA, et al. Exogenously administered prostaglandins modulate pulmonary granulomas induced by Schistosoma mansoni eggs. Am J Pathol. 1983 ; 111 : 78 – 87.en_US
dc.identifier.citedreferenceZurier RB, Damajanov I, Miller PL. Prostaglandin E 1, treatment prevents progression of nephritis in murine lupus erythematosus. J Clin Lab Immunol. 1978 ; 1 : 95 – 106.en_US
dc.identifier.citedreferenceKunkel SL, Ogawa H, Conran PB, et al. Suppression of acute and chronic inflammation by orally administered prostaglandins. Arthritis Rheum 1981 ; 24 : 1151 – 1158.en_US
dc.identifier.citedreferenceZurier RB, Gionfriddo M, Miller P. Treatment of NZB/W (“lupus”) mice with 15(S)-15-methyl PGE 1. Prostaglandin Med. 1980 ; 4 : 281 – 284.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-4362.1986.tb04543.x.pdf
Size:
2.902MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.